chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 1 hour after receiving the vaccine she began to feel dizzy, felt like she was going to pass out, racing heart and pupils became constricted.
Fever, headache, arm "tingly and numb" Hives, weak and "sick"
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) on or about 17-JAN-2008, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 04-AUG-2016, the patient was treated by a physician's assistant for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient was due for surgical intervention to treat her breast cancer [onset unknown; unclear if before or after receiving ZOSTAVAX], but due to her persistent zoster outbreaks and infections on her chest, her surgery was postponed, causing her cancer to spread (onsets unknown). The patient was prescribed VALTREX and hydrocodone/acetaminophen for management of her persistent and painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, breast cancer and surgery was postponed causing her cancer to spread were determined to be medically significant. Additional information has been requested.
07/17/2005 at 17:45, left deltoid and left armpit area with minimal edema and tender to touch.  Face, neck and upper chest redness.  Denies respiratory difficulty, lungs clear.  Injection site with redness.  Medication provided, ibuprofen 400mg and Benadryl 50mg.
Breakthrough covid case. This patient completed series 1/19/21 and became positive 5/14/21
itching p/1st Hep B shot thinks might be fr shot; pt notified; pt wasn't sure what cause the rash; If it was fr all allergies or fr shot; MD gave pt medicine & rash cleared up in 24 hr;
Information has been received from a consumer concerning her "4 1/2 year old" son with peanut allergy and medical history of eczema who in June 2008, was vaccinated with a first dose of MMR II (Dose, route and Lot # not reported). There was no concomitant medication. The consumer stated that on approximately June 2008, "8-10 days after receiving MMR II". Her son developed a fever of 104.5 F and had 2 seizures. TYLENOL and IV fluids were given as a treatment for the events. The patient went to emergency room and was released within 4-5 hours. On an unspecified date the patient recovered. Upon internal review seizures was considered to be an other important medical event. No further information is available.
Administered expired vaccine after the manufacture date of expiration/Dose administered after 30-day use by date or after manufacturer date of expiry; This spontaneous case was reported by a physical therapist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine after the manufacture date of expiration/Dose administered after 30-day use by date or after manufacturer date of expiry) in a 59-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 13-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine after the manufacture date of expiration/Dose administered after 30-day use by date or after manufacturer date of expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine after the manufacture date of expiration/Dose administered after 30-day use by date or after manufacturer date of expiry) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Vial did not undergo any temperature excursions.  No treatment medication was reported by reporter.   This case was linked to MOD-2022-581986 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up was received and included non significant information
A non-serious spontaneous report of "tested positive for Flu B" has been received from a health care professional concerning an eight-year-old male, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received FLUMIST on 26-Sep-2009. At the time of administration the patient had strep throat and "was sick." On 30-Sep-2009, the patient "came back sick and had normal flu symptoms", the patient tested positive for influenza B. Outcome and causality were not reported.
Macular rash starting 1 1/2 wks after MMR. No other symptoms. No treatment.
11/18/2003 @ 11:00: Vaccine administered; 11/18/2003 @ 19:00: Flu-like symptoms-fever, joints ache, shortness of breath, injection site soreness.   11/19/2003: Symptoms persist; 11/20/2003: Symptoms disappear!!
TD was given in left forearm as a intradermal injection instead of a intramuscular injection.
Developed a skin rash that was localized to the back side of my arms. Since then the rash has worsened severely and spread to my neck, torso, and back. I have seemed medical care multiple times. Been given 2 different steroid creams, 3 different antibiotics. The most recent visit (2 days ago) I was given Pepcid and Zyrtec. At this point I cannot sleep due to the heat and pain coming from the sites of the rash and need something to resolve it
Have received all 5 shots. Had COVID; Have received all 5 shots. Had COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Have received all 5 shots. Had COVID". Patient had immediately affects from Pfizer shots. Have received all 5 shots. Had COVID in 11/20 (as reported).   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.
Bruise at site of injection. Approx 19h after injection: fever, chills, fragility, mild nausea, mild headache, unwell  (all similar to flu) for 24h. Treatment: bed rest, hydration and aspirin.  Full recovery by 48h post-injection.
1/12/22 pt to ED with SOB, cough, nausea, diarrhea, decreased appetite x 1 wk; O2 supplementation; admitted; given dexamethasone, remdesivir, ABX; 1/17/22 dc'd to home with hospice (name of hospice not in med records) where pt passed away
Allergic reaction to the COVID-19 Vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Allergic reaction to the COVID-19 Vaccine".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
No adverse reactions after the initial injection.  The day after the 2nd injection I felt a mild ache in my joints (knees, hips, shoulders and elbows) and a feeling of tiredness. I napped on that day, as well as the 2nd full day after the 2nd injection. My joint ache was gone ny the 2nd day. 3rd day I was fine.  About 7 weeks later my joints started to mildly ache, and within a week they were bad enough to keep me from sleeping more than 30 minutes at a time. It would take me about 5 minutes to get out of bed to stand up. I was very aware my symptoms were just about the same the same as after my 2nd. Covid injection, except much much more intense.  I couldn?t stand or sit more than 5 Mins. It hurt to lie down.  Went to the doctor and he diagnosed PMR and treated with 30 mg of prednisone the 1st day, then 15 mg a day after that.  The 1st night after that I slept very well.  My Naturapathic Doctor took a blood sample and verified the PMR finding.  I followed this with Physical Theropy starting about a month later.
10/14/2008: Pt. called stating she had a low grade temp, rash along left flank and 2 "lumps" around the left posterior side of scalp localized described as "sensitive to touch" noted on 10/11 with rash and low grade temp resolved by 10/13. Pt. stated that she did not go to ER or MD upon noting symptoms. Pt. continues to have sentivity and 2 "lumps" on scalp. States that "lumps" are intact, no drainage or scabbing or spreading noted. Pt. encouragd to seek care with PMD or Urgent Care center for f/u.
Initial hoarseness in throat; within 5 minutes, throat felt constricted and I was unable to talk.  Breathing okay but swallowing difficult.  Tightness in jaw and swelling in face and eyes.
Exhausted, very tired; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for self. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced exhausted, very tired on an unspecified date. Outcome of the event was unknown. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Diarrhea followed by vomiting in the middle of the night (c 12 hours after receipt) Also the usual heavy arm & slight sore head. Stomach delicate but alright this morning.
Give 4 immunizations around 10:00 within 1/2 hour after leaving office, baby started crying continously-unconsolable.  Temperature: 98.4F.
This VAERS is to self-report a medication administration error I made 6/22/22 at approximately 16:15pm I prepared and administered 0.2 mL containing 10mcg Pfizer COVID-19 Vaccine from an orange cap vial to patient. Correct dose should have been 0.2 mL containing 3mcg Pfizer COVID=19 Vaccine from a maroon cap vial for this child.  Patient: (upon clinic registration) Patient Name AKA: AGE:3Y (verified by address) DOB: (3¾ yrs) This patient has no history of allergies or severe allergic reactions to medication, animals or food.  I contacted patient?s mother at approximately 19:24pm on my second attempt. I first asked mother how patient was doing. Mother report patient was doing just fine. I proceeded to inform mother of the medication administration error, told her patient had received the dose for a 5-year-old, and apologized for my mistake. I then reviewed the educational information regarding possible side effects and possible adverse effects which we had discussed during patient?s vaccination appointment. This includes going straight to the ER for any signs of anaphylaxis, or any deviation from common expected side effects. I encouraged mother to administer Tylenol or Ibuprofen (may alternate), as had also been discussed earlier, in efforts to keep patient comfortable. I informed her that I would be filing a report to my supervisor and to the state, but that contacting her was my first priority. Mother had asked what the difference in dosing was, and I did not have that information readily available as I was calling from home, but I would find out and get back to her. I stated that I would be calling to follow-up the next day 6/23/22, and to see how both her and the child were doing.  I called 6/23/22 and 6/24/22 to follow up on the child?s well-being, without answer. I left a message both times that I would like to check in on patient and asked how she is doing. I received no return call from the parent and was unable to follow up or determine any subsequent side effects or reactions.
flu like symptoms; aching pain at injection site scale 8/10; chills; Fever 100.3 F; body aches; This is a spontaneous report from a contactable nurse (patient). A 32-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer; lot number: EK9231) intramuscularly at right arm on 04Jan2021 at 02:00 PM at a single dose (dose number: 1) for COVID-19 immunization.  Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Other medications the patient received within 2 weeks of vaccination included multivitamin, glucosamine and fish oil. Facility where the most recent COVID-19 vaccine was administered was at workplace clinic. The patient experienced flu like symptoms, aching pain at injection site scale 8/10, chills, body aches. fever 100.3 F; all with start date on 05Jan2021 at 12:00AM. The events were reported as non-serious. No treatment received for events. The outcome of events was recovering. Since the vaccination, the patient had been tested for COVID-19.
Suffered multiple outbreaks of herpes zoster and postherpetic neuralgia; Suffered multiple outbreaks of herpes zoster and postherpetic neuralgia; This initial spontaneous report was received from a lawyer regarding a case in litigation, referring to a patient (pt) of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On an unknown date, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, dose, route of administration, anatomical location, lot number, and expiration date were not reported). On an unknown date, after receiving zoster vaccine live (ZOSTAVAX) vaccine, the pt suffered multiple outbreaks of herpes zoster and postherpetic neuralgia. As a result of these symptoms, the pt was seen and treated by medical providers and was still under their care. It was also specified that the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury.  The outcome of herpes zoster and postherpetic neuralgia was not recovered. The reporter considered herpes zoster and postherpetic neuralgia to be related to zoster vaccine live (ZOSTAVAX). The events were cosnidered to be  disabling by the reporter.
Immunization given at 6:25 PM.  Rash reaction started within 5 minutes.  Hive-type rash on upper body and face.  SQ Epinephrine 0.2 cc administered at 6:40 PM in L arm.  IM Benadryl 0.4 cc given at same time in R deltoid.  B/P at 6:40 - 120/90, B/P at 6:50 - 116/84. Rash reactin resolved by 7:00 PM.
I have a 3-inch bruise at the injection site; a large red itchy rash; soreness in the arm; a bad headache; body aches.
dministered IPOL to a child that has already received the IPOL vaccine; Initial information received on 08-Aug-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves Child patient unknown gender who experienced dministered ipol to a child that has already received the ipol vaccine while receiving vaccine IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect IPV (VERO) (strength, dose, formulation, route, lot number :not reported) for immunization.  On an unknown date the patient reported administered ipol to a child that has already received the ipol vaccine (extra dose administered) (unknown latency) following the administration of IPV (VERO).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event extra dose administered.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Within 15-minutes of vaccination, the patient reported a gradual onset of nausea. Patient was managed on-site by EMS.
Aches; Headaches; chills; Fever (101-102); This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches), HEADACHE (Headaches), CHILLS (chills) and PYREXIA (Fever (101-102)) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, the patient experienced PAIN (Aches), HEADACHE (Headaches), CHILLS (chills) and PYREXIA (Fever (101-102)). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Aches), HEADACHE (Headaches), CHILLS (chills) and PYREXIA (Fever (101-102)) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Body temperature: 101-102 (High) 101-102 fever.         No relevant concomitant medications were reported.  Action taken with mRNA-1273 in response to events was not applicable.
arm soreness, diarrhea, achiness, flu like symptoms, 97.5 temp
Redness, pain and circular patch on left deltoid @ site of the vaccine, isolated to site, treated with Keflex, prednisone and Ibu.
Subsequent to receiving one dose of varicella virus vaccine live the pt developed varicella, 2 weeks after sibling.
Asthma attack; This is a spontaneous report from a contactable consumer (patient). A 56-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER8735), via an unspecified route of administration, administered in left arm on 23Apr2021 08:15 (at the age of 56 years) as dose 2, single for COVID-19 immunization. The patients medical history included Asthma, diabetes, chronic migraines, sleep apnea. The patients concomitant medication(s) included budesonide, formoterol fumarate (SYMBICORT); clonazepam (KLONOPIN); fluoxetine hydrochloride (PROZAC); fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]); montelukast sodium (SINGULAIR). The patient previously took compazine, prednisone, ceftin, gabapentin, inderal and experienced allergy. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER8727), via an unspecified route of administration, administered in left arm on 25Mar2021 06:30 (at the age of 56 years) as dose 1, single for COVID-19 immunization. The patient did not receive other vaccine in four weeks. The patient did not have covid prior vaccination. The patient did not get covid tested post vaccination. O 23Apr2021 08:30 the patient experienced asthma attack. Proair inhaler was given as a therapeutic measure as a result of asthma attack. The outcome of the events was recovered with sequelae on an unspecified date in Apr2021.   No follow-up attempts are required. No further information is expected.
Started with headache and was achy in joints morning after as well as injection site was inflamed, red, hard and hot to touch. Fever started around 1pm about 101.6. Fever did it break until 4/3 around 12pm. Injection site swelling has increased and is still hot to touch, hard and red but now has also started to itch
itchy bumps in the Botox injection sites on her forehead, pain, swelling and redness for 12 hours; itchy bumps in the Botox injection sites on her forehead, pain, swelling and redness for 12 hours; itchy bumps in the Botox injection sites on her forehead, pain, swelling and redness for 12 hours; itchy bumps in the Botox injection sites on her forehead, pain, swelling and redness for 12 hours; This is a spontaneous report received from a non-contactable consumer. A patient of an unspecified age and gender received Botulinum toxin type A (BOTOX) to the forehead on 17Jan2021 and bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch no/Lot number: not reported) via an unspecified route of administration on 19Jan2021 as dose number unknown, single for COVID-19 immunization. On an unspecified date in Jan2021 (reported as 30 hours later) patient returned to the clinic with itchy bumps in the Botox injection sites on her forehead, pain, swelling and redness for 12 hours. Treatment was not received for the events. Outcome of the events was recovered without treatment on an unspecified date in 2021.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.
they had some vials of Moderna COVID-19 vaccine in the freezer ( Lot Unknown &  Exp. Date:28AUG2021).  On 31AUG2021 they administered expired vaccine to patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (they had some vials of Moderna COVID-19 vaccine in the freezer ( Lot Unknown &  Exp. Date:28AUG2021).  On 31AUG2021 they administered expired vaccine to patients) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (they had some vials of Moderna COVID-19 vaccine in the freezer ( Lot Unknown &  Exp. Date:28AUG2021).  On 31AUG2021 they administered expired vaccine to patients). On 31-Aug-2021, EXPIRED PRODUCT ADMINISTERED (they had some vials of Moderna COVID-19 vaccine in the freezer ( Lot Unknown &  Exp. Date:28AUG2021).  On 31AUG2021 they administered expired vaccine to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not provided by reporter. Treatment information not provided by reporter.   Reporter did not allow further contact
PT complained about a lot of pain about 30 Mins after receiving injection, which approx time given 2:15pm. She continued to have a lot of pain and then reported that she could not lift left arm. Provider on site evaluated her and states sh feels that the injection was given a little high. Pt was Sent to Occupational Health. Pt continues with decreased rom, pain and numbness and tingling in arm.